FDA Avoided Half Of ANDA Pre-Approval Inspections During COVID By Using Alternative Tools

 
• By Derrick Gingery
Files under review
Previous four fiscal quarters showed a more than 50% reduction in the PAI inspections that were needed. • Source: Alamy

More from R&D

More from Pink Sheet